ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.460
+0.120 (2.76%)
At close: Mar 27, 2026

HKG:1541 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
679.56477.6306.98635.21668.33
Short-Term Investments
40-42.5--
Trading Asset Securities
296.46274.52259.09--
Cash & Short-Term Investments
1,016752.12608.56635.21668.33
Cash Growth
35.09%23.59%-4.20%-4.96%-
Accounts Receivable
00.020.040.070.03
Other Receivables
-0.171.040.960.02
Receivables
00.181.081.020.06
Inventory
-24.5476.779.0419.42
Other Current Assets
40.6891.090.296.5916.3
Total Current Assets
1,057867.94686.7651.87704.1
Property, Plant & Equipment
33.5347.71149.39163.89154.12
Other Long-Term Assets
8.176.3538.524.2234.62
Total Assets
1,098922874.59839.98892.84
Accounts Payable
54.9943.2410.81.261.76
Accrued Expenses
-28.5930.8628.9124.17
Short-Term Debt
188.47-59.98--
Current Portion of Long-Term Debt
-100.89---
Current Portion of Leases
6.866.424.45.65.1
Current Income Taxes Payable
-1.110.770.612.96
Current Unearned Revenue
25.2532.9---
Other Current Liabilities
-1.499.1115.362,444
Total Current Liabilities
275.57214.64115.9151.742,478
Long-Term Debt
25.514.5---
Long-Term Leases
7.214.5510.49.0213.44
Total Liabilities
308.27243.69126.360.762,491
Common Stock
431.51407.31374.16356.096.91
Additional Paid-In Capital
-1,093913.46654.47-
Retained Earnings
--1,026-710.35-330.89-1,638
Comprehensive Income & Other
359.93205.21171.0199.5432.24
Total Common Equity
791.44678.9748.29779.22-1,598
Minority Interest
-1.3-0.6---
Shareholders' Equity
790.13678.31748.29779.22-1,598
Total Liabilities & Equity
1,098922874.59839.98892.84
Total Debt
228.03136.3674.7714.6218.54
Net Cash (Debt)
788615.76533.79620.59649.79
Net Cash Growth
27.97%15.36%-13.99%-4.49%-
Net Cash Per Share
1.911.631.481.877.54
Filing Date Shares Outstanding
417.52407.31374.16356.0986.18
Total Common Shares Outstanding
417.52407.31374.16356.0986.18
Working Capital
781.14653.3570.79600.13-1,774
Book Value Per Share
1.901.672.002.19-18.55
Tangible Book Value
791.44678.9748.29779.22-1,598
Tangible Book Value Per Share
1.901.672.002.19-18.55
Machinery
-52.8951.4449.9340.87
Construction In Progress
-27.422.6922.463.22
Leasehold Improvements
-22.4922.4922.4921.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.